Showing Results for
- Academic Journals (27,289)
Search Results
- 27,289
Academic Journals
- 27,289
-
From:Pharmaceutical Technology Europe (Vol. 31, Issue 12) Peer-ReviewedNot since 1923 has the general public of the United Kingdom been sent to the polling stations in the month of December (1). However, the wish of the current UK prime minister, Boris Johnson, to hold a general election a...
-
From:Applied Clinical Trials (Vol. 10, Issue 6) Peer-ReviewedABPI looks at ways to deal with bureaucratic inefficiencies and other problems that it says are hampering drug research in the British pharmaceutical industry. The "considerable bureaucracy and inefficiencies in the...
-
From:Applied Clinical Trials (Vol. 16, Issue 2) Peer-ReviewedFollowing a three-month suspension by the Association of the British Pharmaceutical Industry (ABPI) for breach of Code, Merck Sharp & Dohme's (Munich, Germany) ABPI membership has been reinstated....
-
From:Journal of Diabetes Nursing (Vol. 11, Issue 2) Peer-ReviewedThe publication of The Diabetes Information Jigsaw made for disappointing reading (Association of the British Pharmaceutical Industry et al, 2006). The report investigated information access for people with diabetes and...
-
From:Journal of Men's Health & Gender (Vol. 3, Issue 1) Peer-ReviewedThe Association of the British Pharmaceutical Industry (ABPI) has revised and updated its Code of Practice on pharmaceutical company interactions with healthcare professionals and other stakeholders. The 58-page...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 182, Issue 18) Peer-ReviewedThe Association of the British Pharmaceutical Industry has approved amendments to its code of practice that will require pharmaceutical companies to publicly disclose the amount of money they pay to doctors and other...
-
From:Science (Vol. 307, Issue 5707) Peer-ReviewedFive trade groups representing pharmaceutical companies worldwide are urging members to release more information about clinical trials. However, some see the proposals as a way to stay ahead of legislation that could...
-
From:Nursing Standard (Vol. 21, Issue 35) Peer-ReviewedSUMMARY A code of practice sets out how pharmaceutical companies can promote medicines to health professionals and give information about prescription-only medicines to the public. Keywords Nurse prescribers *...
-
From:Pharmaceutical Technology Europe (Vol. 24, Issue 6) Peer-ReviewedFor some time, stakeholders in the UK have been raising concern: about the country's attractiveness in terms of pharmaceutical investment. In particular, Pfizer's decision last year to exit a key site in Sandwich,...
-
From:Pharmaceutical Technology Europe (Vol. 23, Issue 5) Peer-ReviewedWhen Pfizer decided to close its R&D site in Sandwich attractiveness to the pharma industry. The site employs 2400 people and although Pfizer has stated that some positions will be transferred to other sites or to other...
-
From:Applied Clinical Trials (Vol. 15, Issue 11) Peer-ReviewedThe Association of the British Pharmaceutical Industry (ABPI) suspended Merck Sharpe & Dohme (Whitehouse Station, NJ) for at least three months after determining a management program developed by the company violated...
-
From:Applied Clinical Trials (Vol. 10, Issue 9) Peer-ReviewedThe Institute of Clinical Research (Maidenhead, UK) and the Association of the British Pharmaceutical Industry (London, UK) announced a new scheme to introduce qualifications for clinical research staff in the United...
-
From:Pharmaceutical Technology Europe (Vol. 22, Issue 10) Peer-ReviewedGSK Consumer Healthcare has been accused of breaching the Association of the British Pharmaceutical Industry's Code of Practice. The code covers the promotion of medicines, including journal and direct-mail...
-
From:Applied Clinical Trials (Vol. 15, Issue 9) Peer-Reviewed* In other Abbott news, the Association of the British Pharmaceutical Industry (London, UK) has reinstated Abbott Laboratories' (Abbott Park, IL) membership, which was suspended in February 2005 after the company...
-
From:Applied Clinical Trials (Vol. 15, Issue 12) Peer-ReviewedAs a result of the UK's revised model clinical trials agreement, launched in partnership with the Department of Health, the NHS, the Association of the British Pharmaceutical Industry, and the BioIndustry Association,...
-
From:Pharmacogenomics (Vol. 14, Issue 1) Peer-ReviewedAuthor(s): Christof Koelsch [*] 2 , Joanna Przewrocka 1 , Peter Keeling 1 KEYWORDS : corporate planning; development cost; development time; investment analysis; personalized medicine; pharmaceutical business...
-
From:Pharmaceutical Technology (Vol. 37, Issue 2) Peer-ReviewedSeveral formerly contract-only CMOs have converted, after recent acquisitions, to a more mixed model that combines contract manufacturing with proprietary products. The most prominent examples include Patheon's late...
-
From:MPR Hematology and Oncology Edition (Vol. 6, Issue 1)Gleevec (imatinib; Novartis) has been approved for use in combination with chemotherapy to treat children newly diagnosed with Philadelphia chromosome positive ([Ph.sub.+]) acute lymphoblastic leukemia (ALL). Imatinib...